SomaLogic to Conduct Aptamer Feasibility Study with Beckman Coulter | GenomeWeb

NEW YORK, July 23 - SomaLogic said today it has signed an agreement with Beckman Coulter to conduct a feasibility study on the integration of its aptamer technology with Beckman Coulter's liquid handling workstation and plate and array reader platforms.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.